Long-term efficacy and safety of sildenafil for patients with erectile dysfunction

Journal of the Chinese Medical Association

Volumn 66, Issue 8, 2003, Pages 480-486

  Sheu, Jow Yu ^a,b   Chen, Kuang Kuo ^a,b   Lin, Alex T L ^a,b   Chang, Yen Hwa ^a,b   Wu, Howard H H ^a,b   Huang, William J S ^a,b   Hsu, Yen Shen ^a,b   Kuo, Junne Yih ^a,b   Chung, Hsiao Jen ^a,b   Chang, Luke S ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Efficacy; Erectile dysfunction; Safety; Tachyphylaxis

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COLOR VISION DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; FOLLOW UP; GASTROINTESTINAL DISEASE; GENERAL HOSPITAL; HEART PALPITATION; HOT FLUSH; HUMAN; HYPOTENSION; LIBIDO; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PENIS ERECTION; PRESCRIPTION; SEXUAL INTERCOURSE; TACHYCARDIA; TAIWAN; TREATMENT FAILURE; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PENILE ERECTION; PIPERAZINES; SEXUAL BEHAVIOR; TREATMENT OUTCOME;

EID: 0142029971     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. NIH consensus development panel on impotence. JAMA 1993;270:83-90.
2. Feldman HA, Goldstein I, Hatzichchristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994; 151:54-61.
3. Wang YX, Leng J, Chen B, Huang XY. The prevalence of erectile dysfunction in elder adults in Shanghai: an analysis of 1582 cases. Int J Impot Res 1997;19(suppl 1):S45.
4. Rizk EG, Harry R, Riydh T, Thomas K, Harry C. Long-term efficacy of sildenafil and tachyphylaxis effect. J Urol 2001; 166:927-31.
5. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-404.
6. Ronald L, Carol JB, William DB, William HB, Stanley EA, Vera JS, Richard LS. Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the erectile dysfunction inventory of treatment satisfaction questionnaire. Urology 2001;57:960-5.
7. Chen KK, Hsieh JT, Huang ST, Jiaan DB-P, Lin JS-N, Wang CJ. ASSESS-3: A randomized, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan. Int J Impot Res 2001;13:221-9.
8. Tan HM, Moh CL, Mendoza JB, Gana T, Albano GJ, Cruz D, et al. Asian Sildenafil Efficacy and Safety Study (ASSESS-1): A double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. Urology 2000;56:635-40.
9. Kim YC. Algorithm for diagnosis and treatment of erectile dysfunction in the era of sildenafil citrate. Int J Androl 2000; 23:85-6.
10. Garg RK, Khaishgi A, Dandona P. Is management of impotence with sildenafil changing clinical practice? Lancet 1999; 353:375-6.
11. Willem M, Rene' FK, Pieter V. Comparative tolerability and efficacy of treatments for impotence. Drug Safety 1999;20: 133-46.
12. Rosen RC, Riley A, Wangner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
13. Marshall GA, Breza J, Lue TF. Improved hemodynamic response after long-term intracavernous injection for impotence. Urology 1994;43:844-8.
14. Brock G, Tu LM, Linet OI. Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urology 2001;57:536-41.